Objectives We conducted a systematic literature review and meta-analysis of observational
studies to investigate the association between diabetes, hypertension, body mass index …

An update is available for this article. Background: The role of angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in coronavirus disease …

Many countries have seen a two-wave pattern in reported cases of coronavirus disease-19
during the 2020 pandemic, with a first wave during spring followed by the current second …

After initially hypothesizing a positive relationship between use of renin-angiotensin-
aldosterone system inhibitors and risk of coronavirus disease 2019 (COVID-19), more recent …

Importance SARS-CoV-2 viral entry may disrupt angiotensin II (AII) homeostasis,
contributing to COVID-19 induced lung injury. AII type 1 receptor blockade mitigates lung …

The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …

Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID‐19) is a huge
determinant of prognosis during the acute phase of the disease. However, little is known …

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies,
observational in design, appear to use biased methods that can distort the interaction …

Background: Protease inhibitors have been considered as possible therapeutic agents for
COVID-19 patients. Objectives: To describe the association between lopinavir/ritonavir …

Background Despite the availability of extensive literature on the effect of angiotensin‐
converting enzyme inhibitors (ACEIs)/angiotensin‐receptor blockers (ARBs) on COVID‐19 …